Company | Date | Price Target | Rating | Analyst |
---|---|---|---|---|
9/9/2024 | Hold → Sell | Tudor, Pickering, Holt & Co. | ||
7/17/2024 | $27.00 | Neutral | Mizuho | |
4/10/2024 | $23.00 | Sector Weight → Overweight | KeyBanc Capital Markets | |
4/4/2024 | Mkt Perform | JMP Securities | ||
2/26/2024 | $19.00 | Market Perform | Leerink Partners | |
1/16/2024 | Sector Perform → Sector Underperform | Scotiabank | ||
12/7/2023 | $17.00 | Neutral | UBS | |
12/5/2023 | Sector Weight | KeyBanc Capital Markets |
144 - Certara, Inc. (0001827090) (Subject)
8-K - CVR ENERGY INC (0001376139) (Filer)
10-Q - Certara, Inc. (0001827090) (Filer)
4 - Certara, Inc. (0001827090) (Issuer)
4 - EXPONENT INC (0000851520) (Issuer)
4 - EXPONENT INC (0000851520) (Issuer)
RADNOR, Pa., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (NASDAQ:CERT), a global leader in model-informed drug development, today announced that Company management will participate in the following investor conferences: Morgan Stanley 22nd Annual Global Healthcare ConferenceDate and Time: Wednesday, September 4 at 4:05 p.m. ET Baird Global Healthcare ConferenceDate and Time: Wednesday, September 11 at 10:15 a.m. ET Live webcasts for each of the conferences will be available on Certara's investor relations website at https://ir.certara.com and will be available for replay for at least 90 days thereafter. About CertaraCertara accelerates medicines using biosimulation software, techno
RADNOR, Pa., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (NASDAQ:CERT), a global leader in model-informed drug development, today announced the launch of Phoenix™ version 8.5. Phoenix is the pharmaceutical industry's gold standard in pharmacokinetic/pharmacodynamic (PK/PD) and toxicokinetic modeling and simulation software. The Phoenix Platform is used by more than 75 of the top 100 pharmaceutical companies worldwide. Eleven regulatory agencies, including the U.S. FDA, Japan PMDA, and China NMPA, rely on Phoenix to evaluate life-saving drug candidates. Version 8.5 is the latest release from Certara's Phoenix Platform, available as a hosted solution for maximum performance and lower tot
RADNOR, Pa., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (NASDAQ:CERT), a global leader in model-informed drug development, today reported its financial results for the second quarter of fiscal year 2024. Second Quarter Highlights: Revenue was $93.3 million, compared to $90.5 million in the second quarter of 2023, representing growth of 3%. Software revenue was $38.2 million, compared to $33.7 million in the second quarter of 2023, representing growth of 13%.Services revenue was $55.1 million, compared to $56.7 million in the second quarter of 2023, representing a decline of 3%. Net loss was $12.6 million, compared to a net income of $4.7 million in the second quarter of 2023.Adjuste
RADNOR, Pa., May 21, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (NASDAQ:CERT), a global leader in model-informed drug development, has appointed Rona Anhalt as Chief Human Resources Officer and Daniel Corcoran as General Counsel. "Rona and Daniel are leaders in their fields. They have proven track records of growing teams and building high-performing businesses," said William F. Feehery Ph.D., CEO, Certara. "I'm confident they will further Certara's mission of accelerating medicines to patients through the delivery of solutions that improve the entire drug research and development process." Ms. Anhalt will drive Certara's human capital management strategy. She will lead the company's global
Reported Net Income of $88.3 MillionAdjusted EBITDA of $215.6 MillionAdjusted Net Income of $97.3 Million PURCHASE, N.Y., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Atlas Air Worldwide Holdings, Inc. (NASDAQ:AAWW) today announced second-quarter 2022 net income of $88.3 million, or $2.65 per diluted share, compared with net income of $107.1 million, or $3.53 per diluted share, in the second quarter of 2021. On an adjusted basis, EBITDA totaled $215.6 million in the second quarter this year compared with $243.7 million in the second quarter of 2021. Adjusted net income in the second quarter of 2022 totaled $97.3 million, or $3.36 per diluted share, compared with $121.8 million, or $4.10 per diluted
PRINCETON, N.J., July 25, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (NASDAQ:CERT), a global leader in biosimulation, today announced the appointment of Rosemary Crane to its Board of Directors, effective July 21, 2022. Her appointment brings the company's board of directors to eleven members. "We are excited to welcome an accomplished business leader with a proven track record of success join Certara's Board," said William F. Feehery, PhD, CEO of Certara. "Rose's experience in executive leadership and expertise in commercialization will provide immense value as the Company grows its impact on the biopharmaceutical industry worldwide." Ms. Crane has more than 35 years of experience in the ph
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout. Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our Analyst Stock Ratings page. Traders can sort through Benzinga's extensive database of analyst ratings, including by analyst accuracy. Below are the ratings of the most accurate analysts for three high-yielding stocks in the energy sector. CVR Energy, Inc. (NYSE:CVI) Dividend Yield: 7.88% Scotiabank analyst Paul Cheng maintained a Sector Underperform rating and cut the p
Mizuho analyst Nitin Kumar initiates coverage on CVR Energy (NYSE:CVI) with a Neutral rating and announces Price Target of $27.
Scotiabank analyst Paul Cheng maintains CVR Energy (NYSE:CVI) with a Sector Underperform and lowers the price target from $29 to $24.
SC 13D/A - CVR ENERGY INC (0001376139) (Subject)
SC 13G/A - EXPONENT INC (0000851520) (Subject)
SC 13G/A - CVR ENERGY INC (0001376139) (Subject)
RADNOR, Pa., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (NASDAQ:CERT), a global leader in model-informed drug development, today reported its financial results for the second quarter of fiscal year 2024. Second Quarter Highlights: Revenue was $93.3 million, compared to $90.5 million in the second quarter of 2023, representing growth of 3%. Software revenue was $38.2 million, compared to $33.7 million in the second quarter of 2023, representing growth of 13%.Services revenue was $55.1 million, compared to $56.7 million in the second quarter of 2023, representing a decline of 3%. Net loss was $12.6 million, compared to a net income of $4.7 million in the second quarter of 2023.Adjuste
Second quarter net income attributable to CVR Energy stockholders of $21 million; EBITDA of $103 million; adjusted EBITDA of $87 millionSecond quarter earnings per diluted share of 21 cents and adjusted earnings per diluted share of 9 centsAnnounced cash dividend of 50 cents per shareCVR Partners announced a cash distribution of $1.90 per common unit SUGAR LAND, Texas, July 29, 2024 (GLOBE NEWSWIRE) -- CVR Energy, Inc. (NYSE:CVI, "CVR Energy" or the "Company"))) today announced net income attributable to CVR Energy stockholders of $21 million, or 21 cents per diluted share, and EBITDA of $103 million for the second quarter of 2024, compared to net income attributable to CVR Energy stockho
MENLO PARK, Calif., July 25, 2024 (GLOBE NEWSWIRE) -- Exponent, Inc. (NASDAQ:EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.28 per share of common stock to be paid on September 20, 2024, to all common stockholders of record as of September 6, 2024. Exponent has paid, and expects to continue to pay, quarterly dividends each year in March, June, September, and December. Future declarations of quarterly dividends and the establishment of future record and payment dates are subject to the final determination of Exponent's Board of Directors. "Exponent continues to deliver on its commitment to shareholders through our quarterly cash dividend
Tudor, Pickering, Holt & Co. downgraded CVR Energy from Hold to Sell
Mizuho initiated coverage of CVR Energy with a rating of Neutral and set a new price target of $27.00
KeyBanc Capital Markets upgraded Certara from Sector Weight to Overweight and set a new price target of $23.00